Lara S Izotova

Title: The Innovative Contributions of Lara S Izotova

Introduction

Lara S Izotova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the production of human leukocyte interferon alpha-2. Her innovative methods have the potential to impact medical treatments and therapies.

Latest Patents

Lara holds a patent for a method of producing human leukocyte interferon alpha-2. This method involves submerged cultivation of a producer strain, Pseudomonas species VG-84, which carries a plasmid with the inserted gene of human leukocyte interferon alpha-2. The strain is deposited in the collection of microorganism cultures at the USSR Antibiotics Research Institute under Reg. No. 1742. The cultivation process occurs in a nutrient medium containing sources of carbon and nitrogen, mineral salts, and growth stimulants, under aeration and in the presence of antibiotics such as streptomycin or tetracycline. The process concludes with the isolation and purification of the end product.

Career Highlights

Lara is affiliated with the Vsesoyuzny Nauchno-issledovatelsky Institut Genetiki, where she continues her research and development in genetic engineering and biotechnology. Her work has garnered attention for its innovative approach and practical applications in medicine.

Collaborations

Lara has collaborated with notable colleagues, including Vladimir G Debabov and Jury Dmitrievich Tsygankov. Their combined expertise has contributed to advancements in their respective fields.

Conclusion

Lara S Izotova's contributions to biotechnology, particularly through her patented method for producing human leukocyte interferon alpha-2, highlight her role as an influential inventor. Her work continues to pave the way for future innovations in medical treatments.